| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a2bcaf91101a370a3d64e3190366357f |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-162
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-16 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-16 |
| filingDate |
2018-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3fd24afbaf989db64086e55d0ef542de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c5eea29bba69ba1e336278f32b1cbafa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a13d276f77f365947b4979dfce72f8a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4eaabe0772cd4270cf77bea5612da574
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_12f42acfccd541ce4e564c900f21a5e9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d271a199f586b71bc5ef40ea73cbfd5b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4ebf45286db64d3eb7b39cfd87a40b45 |
| publicationDate |
2020-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-3630193-A1 |
| titleOfInvention |
Nanostructure with a nucleic acid scaffold and virus-binding peptide moieties |
| abstract |
The present invention relates to a nanostructure comprising: a) a nucleic acid scaffold; and b) at least two peptide moieties, wherein the at least two peptide moieties specifically bind to a molecule expressed on the surface of a virus and are attached to the nucleic acid scaffold, wherein the structure of the nucleic acid scaffold is selected from the group of: i) a linear nucleic acid scaffold, wherein the at least two peptide moieties are each attached at or near different ends of the nucleic acid scaffold; and ii) a branched nucleic acid scaffold, wherein the at least two peptide moieties are each attached to a different branch of the scaffold. The invention furthermore relates to the nanostructure of the invention for use as a medicament, and more specifically for use in the treatment of viral infections. The invention also relates to the nanostructure of the invention for the use in diagnostic purposes and in methods of detecting whether a virus is present in a sample. |
| priorityDate |
2017-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |